InsidersTradesSigma
Browse the full record of transactions filed by Leiderman Elisabeth, Director. Director active across 1 company, notably bluebird bio, Inc.. In total, 5 disclosures have been recorded. Activity tracked since 15 October 2021. The latest transaction was filed on 22 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Elisabeth Leiderman is a Director at bluebird bio, Inc. In this role, she participates in the governance of the company, bringing her expertise to guide strategic decisions. Her commitment to biopharmaceutical innovation is an asset for bluebird bio.